These abnormal epigenetic modifications associated prostate cancer include DNA methylation, histone methylation and histone acetylation, etc. For example, HDAC1 (Histone deacetylase 1), HDAC2 and HDAC3 are strongly expressed in prostate cancer [7, 8]. This evidence concerns the gene HDAC3 and prostate carcinoma.